Re-Entry, Re-Integration, and Re-Training Supplement Funding

Please note: As of January 24, 2025, the NIH has closed notice PA-23-189, “Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)”.

 

Are you a UIC faculty member looking for ways to recruit and fund postdoctoral researchers? Or are you a trainee considering UIC for your postdoctoral training? Administrative Supplements from the National Institutes of Health (NIH) can support scholars who have identified an NIH-funded lab in which to work. Administrative supplements benefit both postdocs and faculty by providing salary support to outstanding candidates with a quick response turnaround and high funding rate while showing a commitment to a scholar's career by NIH.

Updates on Federal Research Agency Policy Changes

NIH Administrative Supplements provide additional funding to faculty members and other principal investigators (PIs) who hold active NIH grants (i.e. “parent grants”). Re-Entry, Re-Integration, and Re-Training Supplements support trainees by providing funding for postdoctoral training (and other career levels ranging from high school to junior faculty).

 

According to NOT-OD-23-170, the goal of this program is to provide support for a mentored research training experience for individuals with high potential to re-enter, re-integrate, or re-train into an active research career, after an interruption for family responsibilities or other qualifying circumstances. It is anticipated that by the completion of the supplement support period, the awardee will be prepared to apply for a fellowship (F), career development (K) award, a research award (R), or other types of independent research support. Applications for this initiative must be submitted using PA-20-272 or its subsequent reissued equivalent. For a list of eligible Activity Codes, see PA-18-592.

The re-entry supplements is intended to provide mentored research training opportunities for a minimum of 1 year to re-enter biomedical research to individuals with doctoral degrees who have interrupted their research careers for family responsibilities or other qualifying circumstances.

The re-integration program addresses the critical need to provide individuals who are adversely affected by unsafe or discriminatory environments resulting from intimidation or bullying, to rapidly transition into new safer, and more supportive research environments. The goal is to provide these individuals with a timely and seamless continuation of their research training program and to safely reintegrate into the biomedical workforce. Unsafe environments may consist of threatening behavior such as sexual and gender harassment; harassment based on being a member of a racial, ethnic, sexual, or gender minority group; disability-based aggression; aggressions associated with religion; and other similar circumstances.

The re-training and re-tooling program provides support and protected time for a mentored research experience that allows an early or mid-career candidate to obtain new skills that can allow the candidate to go to a new research direction while augmenting the parent grant. The intent of the program is to facilitate inter-disciplinary partnerships and cross-sector collaborations that would enable the scholar to acquire specialized skills and novel perspectives that would augment the chances for the advancement of their careers.

  • US citizens, non-citizen nationals, or permanent residents
  • Must be planning a career in biomedical, behavioral, clinical, translational, or social science research
  • Re-entry: In general, the duration of the career interruption should be at least six months for re-entry purposes, and no more than eight years.
    • Examples of qualifying interruptions for re-entry supplements include, but are not limited to: a complete or partial hiatus from research activities for child-rearing; an incapacitating illness or injury of the candidate, spouse, partner, or a member of the immediate family; job offers rescinded as a result of natural disasters or public health emergencies (e.g., COVID-19), relocation to accommodate a spouse, partner, or another close family member; pursuit of non-research endeavors that would permit earlier repayment of debt incurred in obtaining a doctoral degree; and military service
    • Some ICs require that the duration of the career interruption is at least 1 year
  • Re-integration: Candidates seeking to transition out of unsafe research environments because of discriminatory and unlawful harassment are eligible to apply for re-integration supplements as soon as supplement support to continue research training in a new and safe research environment has been identified.
  • Re-training and re-tooling: Candidates who have at least 2 years of post-doctoral research experience, scientists appointed as Research Associates, Instructors, Assistant or Associate Professors, and other scientists employed in government or industry with experiences equivalent to those of post-doctoral candidates are eligible to apply.
  • Candidates may receive support from only one supplement program at a time, but may be supported by more than one supplement during the development of their research careers.
  • Some ICs require that candidates must already have a doctoral degree at the time of application
  • Some ICs require that candidates must have already been in a postdoctoral position at the time they left active research
  • Not all ICs participate in the re-training and re-tooling portion of the program
  • Eligible grant activity codes for the parent grant (PA-18-592):
    • DP1, DP2, DP4, DP5
    • G12
    • P01, P20, P2C, P30, P40, P41, P50, P51, P60, PM1, PN2
    • R01, R18, R21, R24, R33, R34, R35, R37, R41, R42, R43, R44, R61, RC1, RC2, RC3, RC4, RF1, RM1
    • S06
    • U01, U10, U18, U19, U24, U2C, U41, U42, U44, U54, U56, UC2, UF1 UG1, UG3, UH2, UH3, UM1, UM2
  • The P20, P30, and P60 award mechanisms are eligible for supplements only if they contain research components
  • Supplements should support the aims of the parent grant
  • Budget requests must not extend beyond the project end date and must fall within the budget cycle of the parent grant
  • A parent grant may support only one individual on a supplement
  • Not all participating NIH Institutes and Centers (ICs) support all the activity codes listed above. Not all ICs participate in the re-training and re-tooling portion of the program. Each IC also has its own requirements for years remaining on the parent grant to submit a supplement and other eligibility requirements. Therefore, before preparing a re-entry, re-integration, or re-training supplement application, it is IMPERATIVE that the principal investigator reach out to:
    1. The institute specific contacts listed here
    2. The program officer (PO) for the parent grant
    3. Any institute-specific contacts listed in the specific supplement application instructions for that particular IC

The information below is current as of June 1, 2024. However, this information often changes and each IC has its own:

  • Submission and funding deadlines
  • Application instructions
  • Years of funding available for a postdoc candidate
  • Eligibility requirements (both for a postdoc candidate and for the PIs parent grant)
  • Funding priorities

Therefore, before preparing a re-entry, re-integration, or re-training supplement application, it is IMPERATIVE that the principal investigator reach out to:

  1. The institute specific contacts listed here
  2. The program officer (PO) for the parent grant
  3. Any IC-specific contacts listed in the specific supplement application instructions for that particular IC
Institute Specific Information Minimum Time Remaining on Parent Grant Required Application Deadlines Funding Information Postdoc Support Available
National Cancer Institute (NCI) 2 years remaining at the time of application submission Applications accepted October 1-December 1 and February 1-March 31 Funding decisions are anticipated in March and June, respectively May be supported for the duration of the parent grant, but typically for 3 years or less
National Eye Institute (NEI) Unspecified Rolling acceptance
National Heart, Lung, and Blood Institute (NHLBI) 1 year remaining at time of award Rolling acceptance All applications should arrive at least three months before the requested start date. Applications seeking awards before the end of a fiscal year (September 30) must be received no later than May 31 A minimum of 1 year and a maximum of 3 years of support will be awarded
National Human Genome Research Institute (NHGRI) 1 year remaining at time of award Rolling acceptance Administrative supplements may be submitted throughout the fiscal year, but should be requested at least 90 days prior to the anticipated need and no later than by May 15
National Institute on Aging (NIA) 2 years of active status left at the time of supplement application unless the performance period of the grant is less than 2 years Rolling acceptance 2 years of active status left at the time of supplement application unless the performance period of the grant is less than 2 years Maximum length of award is 2 years
National Institute on Alcohol Abuse and Alcoholism (NIAAA) Unspecified
National Institute of Allergy and Infectious Diseases (NIAID) 2 years remaining at time of application submission Rolling acceptance Applications are reviewed 4 times per year (November, February, April, May) and are awarded 8-10 weeks after review. The cutoff to receive an award in the current fiscal year is April 1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Unspecified Rolling acceptance between October 1 and May 31
National Institute of Biomedical Imaging and Bioengineering (NIBIB) Unspecified
National Institute of Child Health and Human Development (NICHD) Unspecified Applications accepted on September 15, January 15, and May 15 Funding decisions: December, April, and August with funding start dates of January, June, and September
National Institute on Deafness and Other Communication Disorders (NIDCD) Unspecified Rolling acceptance Minimum length of award is 1 year
National Institute of Dental and Craniofacial Research (NIDCR) Unspecified Rolling acceptance Applications are reviewed on a continuous basis. The cutoff for current fiscal year funding is July 15
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) The parent grant must have support remaining for a “reasonable period” (usually 2 years or more) at the time of award Applications received by 5 pm on the first business day of the month are reviewed at the end of each review month (from October through June) Funding decisions will be made three times per year in January, April, and June Maximum length of award is 2 years
National Institute on Drug Abuse (NIDA) Unspecified
National Institute of Environmental Health Sciences (NIEHS) The parent grant must have a reasonable period of research support (usually 2 years or more) remaining at the time of the supplemental award Rolling acceptance Re-entry supplement applications are reviewed every other month to minimize the time from application to award. The cutoff to receive an award in the current fiscal year is June 1
National Institute of General Medical Sciences (NIGMS) The parent grant must have a reasonable period of research support remaining at the time of the supplemental award Rolling acceptance, but applications submitted after May 1 may not be awarded until the following November due to the change in fiscal year on October 1 Funding decisions take approximately 12 weeks following receipt of the application Maximum length of award is 3 years
National Institute of Mental Health (NIMH) At the time of submission, the proposed supplement activities must be within the approved project period for the parent award. The duration of the proposed supplement should be sufficient in length to provide a meaningful career development experience for the candidate and the duration must be fully justified Rolling acceptance Applications are reviewed on a regular schedule. Funding decisions take about 10 weeks. The cutoff to receive an award in the current fiscal year is April 1 A two-year supplement period is typically appropriate for postdocs. In some circumstances, less than two years might be accommodated, but potential applicants considering a supplement period less than two years would require a detailed explanation
National Institute on Minority Health and Health Disparities (NIMHD) Unspecified
National Institute of Neurological Disorders and Stroke (NINDS) 1 year remaining at the time of award Rolling acceptance Funding decisions take 1-2 months following application submission Minimum length of award is 1 year, maximum length is 3 years
National Institute of Nursing Research (NINR) Unspecified
National Library of Medicine (NLM) Unspecified Rolling acceptance
John E. Fogarty International Center for Advanced Study in the Health Sciences Unspecified
National Center for Complementary and Integrative Health (NCCIH) Unspecified Applications are accepted four times a year: January 2nd, April 1st, July 1st, or October 1st Funding will be provided for 1 year and will consider a 1 year renewal application depending on progress
National Center for Advancing Translational Sciences (NCATS) 2 years remaining at the time of application submission The submission deadline is November 1 of each year Applications will be evaluated and decisions will be made within 2-3 months The requested time should be 2 years
Office of Research Infrastructure Programs (ORIP) Unspecified
Office of Research on Women’s Health (ORWH) Unspecified Minimum length of award is 1 year
NIH Common Fund Unspecified

The following faculty members have active NIH parent grants that are potentially eligible to receive Administrative Supplement funding from NIH. These faculty members have indicated their interest in recruiting postdocs through this supplement mechanism. Eligible prospective postdocs, please read through the database of projects and contact any faculty members of interest directly. To learn more about a potential project, you can:

 

PI NamePI EmailUIC DepartmentProject TitleNIH ICProject Award NumberProject End Date
Alonzo, Francisfalonzo@uic.eduMicrobiology & ImmunologyIntercellular Communication and Pheromone Maturation in Gram-Positive BacteriaNIAIDR01 AI153059April 30, 2025
Alonzo, Francisfalonzo@uic.eduMicrobiology & ImmunologyStaphylococcus aureus Survival During Nutrient Restriction and Suppression of Host ImmunityNIAIDR01 AI120994February 28, 2026
Alsberg, Ebenealsberg@uic.eduBiomedical EngineeringIndividual cell bioprinting to generate multi-tissue type condensations for osteochondral tissue regenerationNIAMSR01 AR081448 February 29, 2028
Argos, Mariaargos@uic.eduEpidemiology and BiostatisticsImpact of Metals on Biological Aging and Cardiometabolic Traits in AdolescentsNIEHSR01 ES033883March 31, 2027
Bhatt, Tanvitbhatt6@uic.eduPhysical TherapyNeuromechanisms of falls in older adults with MCI: Targeting assessment and training of reactive balance controlNIAR01 AG073152August 31, 2026
Bronas, Ulfbronas@uic.eduBehavioral Nursing ScienceAccelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity (EXEC-study)NIAR01 AG076456April 30, 2027
Caskey, Rachelrcaskey@uic.eduMedicine-Academic Internal MedicineImproving Maternal Health Through an Adaptation of a Two-Generation Postpartum Care Model in Diverse SettingsNICHDR21 HD112104August 31, 2024
Coloff, Jonathancoloff@uic.eduPhysiology & BiophysicsTargeting Serine Auxotrophy in Luminal Breast CancerNCIR37 CA251216February 28, 2026
Cologna, Stephaniecologna@uic.eduChemistryNovel Therapeutic Approaches for NPC DiseaseNINDSR01 NS124784June 30, 2027
Cordoba-Chacon, Josejcordoba@uic.eduMedicine-Endocrinology/Diabetes & MetabolismPPARgamma-regulated mechanisms in hepatocytes that promote NAFLDNIDDKR01 DK131038January 31, 2027
DiPietro, Luisaldipiet@uic.eduPeriodonticsComplexity and the Wound Healing ResponseNIGMSR35 GM139603December 31, 2025
Djalilian, Aliadjalili@uic.eduOpthlamology & Visual SciencePhase I Study of Mesenchymal Stromal Cell Secretome for Promoting Corneal RegenerationNEIUH3 EY031809September 9, 2024
Dykens, Andrewjdykens@uic.eduFamily & Community MedicineAdaptation and implementation of a patient navigation program for cervical cancer screening across contexts in SenegalNCIR01 CA258683March 31, 2027
Er, Emraheer@uic.eduPhysiology & BiophysicsMicrosurveillance in Breast Cancer MetastasisNCIR37 CA269370August 31, 2027
Federle, Michaelmfederle@uic.eduPharmaceutical SciencesMacrophage Immunosuppression by Quorum-Induced Streptococcus pyogenesNIAIDR01 AI162679June 30, 2026
Fukuchi, Ken-ichirokfukuchi@uic.eduCancer Biology & PharmacologyRole of MyD88 signaling in systemic inflammation and Alzheimer diseaseNIAR01 AG069447April 30, 2026
George, Anneanneg@uic.eduOral BiologyRole of DMP1 Mediated Paracrine Signaling in VasculogenesisNIDCRR01 DE031737June 30, 2027
Gowrishankar, Swethaswethag@uic.eduAnatomy & Cell BiologyElucidating the role of Adaptor Protein complex-4 in regulating axonal autophagic and lysosomal pathwaysNIAR01 AG074248May 31, 2027
Hay, Nissimnhay@uic.eduBiochemistry & Molecular GeneticsHexokinase 2 and cancer therapyNCIR01 CA258299June 30, 2026
He, Bintshuo@uic.eduMicrobiology & ImmunologyViral determinants in HSV virulenceNIAIDR01 AI148148April 30, 2025
Hu, Guochanggchu@uic.eduAnesthesiologyTargeting the host immune response during sepsisNHLBIR01 HL152696June 30, 2024
Hu, Samuelyshu@uic.eduChemistryUltrasensitive quantification of cytokine release from T cellsNIGMSR35 GM146786May 31, 2027
Kazlauskas, Andriusak20@uic.eduOpthlamology & Visual ScienceAnti-VEGF-mediated barrier closureNEIR01 EY031350August 31, 2025
Kuchay, Shafikuchay@uic.eduBiochemistry & Molecular GeneticsProteostasis at cellular membranesNIGMSR35 GM137452July 31, 2025
Lash, Jamesjplash@uic.eduMedicine-NephrologyUniversity of Illinois at Chicago KPMP CKD Recruitment SiteNIDDKU01 DK133081June 30, 2027
Lash, Jamesjplash@uic.eduMedicine-NephrologyChronic Renal Insufficiency Cohort StudyNIDDKU01 DK060980June 30, 2023
Lash, Jamesjplash@uic.eduMedicine-NephrologyChicago Kidney Urology Hematology Network for Citywide Research Training and Career DevelopmentNIDDKU2C DK129917May 31, 2026
Lazarov, Orlyolazarov@uic.eduAnatomy & Cell BiologyHippocampal neurogenesis in cognitive function and dysfunction in Alzheimer's diseaseNIAR01 AG076940April 30, 2027
Lazarov, Orlyolazarov@uic.eduAnatomy & Cell BiologyThe role of APP in neurogenesis and AD in Down syndromeNIARF1 AG079002August 31, 2025
Lee, Stevessylee@uic.eduPharmaceutical SciencesIntegrated three-dimensional (3D) microscopy for a spatial pharmacology atlas of macromolecular drugs in the tissue microenvironmentNIGMSR35 GM142743August 31, 2026
Li, Hongjinhongjin@uic.eduHuman Development Nursing ScienceFeasibility of Implementing Acupuncture into a Federally Qualified Health Center to Alleviate Multiple Symptoms Among Breast Cancer Survivors Receiving Endocrine therapyNCCIHR34 AT012084May 31, 2025
Ma, Aoaoma@uic.eduBiomedical EngineeringUnderstanding allostery from the perspective of protein dynamics and energy flowsNIAIDR21 AI162197July 31, 2024
Macduff, Donnadmacduff@uic.eduMicrobiology & ImmunologyDefining the differential roles of HOIL1 and the Linear Ubiquitin Chain Assembly Complex in interferon induction by MDA5 and RIG-I during viral infectionNIAIDR01 AI150640May 31, 2026
Madhavan, Sangeethasmadhava@uic.eduPhysical TherapyCortical priming to optimize gait rehabilitation post strokeNICHDR01 HD075777July 31, 2025
Mankad, Nealnpm@uic.eduChemistryMultimetallic Catalysis in Biology and SynthesisNIGMSR35 GM140850May 31, 2026
Mankin, Alexandershura@uic.eduPharmaceutical SciencesAdvancing ribosome-targeting antibacterial peptides with a unique mechanism of actionNIAIDR01 AI162961January 31, 2027
Marai, Georgeta-Elisabetagmarai@uic.eduComputer ScienceLongitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer TherapyNCIR01 CA258827February 28, 2026
Martin, Mollymollyma@uic.eduPediatricsCoordinated Oral Health Promotion (CO-OP) Chicago Cohort StudyNIDCRU01 DE030067June 30, 2026
Mehta, Taratmehta@uic.eduPsychiatryPatient Navigators for Children's Community Mental Health Services in High Poverty Urban CommunitiesNIMHR01 MH123424February 28, 2026
Mermelstein, Robinrobinm@uic.eduPsychologyContext, Subjective and Cognitive Experiences with Patterns of Tobacco and Cannabis Co-Use in Young AdultsNIDAR01 DA051157April 30, 2025
Mermelstein, Robinrobinm@uic.eduCenter for Clinical and Translational ScienceClinical and Translational Science AwardNCATSUL1 TR002003May 31, 2025
Mo, Garygmo@uic.eduPharmacology & Regenerative MedicinePyroptosis is a Trial-by-Fire ProgramNIGMSR35 GM146936July 31, 2027
Naba, Alexandraanaba@uic.eduPhysiology & BiophysicsThinking outside the cell: Leveraging HuBMAP data to build the human ECM atlasNHGRIU01 HG012680April 30, 2026
Naba, Alexandraanaba@uic.eduPhysiology & BiophysicsEnhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrixNCIR21 CA261642August 31, 2025
Nakamura, Torunakamut@uic.eduBiochemistry & Molecular GeneticsRegulation of Telomere Maintenance in Fission YeastNIGMSR01 GM143316August 31, 2026
Ong, Sang Gingsangging@uic.eduPharmacology & Regenerative MedicineRab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathyNHLBIR01 HL148756March 31, 2025
Reed, Davidreedd@uic.eduOral BiologyCell-Matrix Regulation of Fibrochondrocytes in TMJ OANIDCRR01 DE029835March 31, 2025
Richner, Justinrichner@uic.eduMicrobiology & ImmunologyDengue virus mRNA lipid nanoparticle vaccineNIAIDR01 AI150672July 31, 2025
Riley, Andrewapriley@uic.eduPharmaceutical SciencesSynthesis and Evaluation of Alkaloids to Probe Membrane ReceptorsNIGMSR35 GM147005June 30, 2027
Roitman, Mitchellmroitman@uic.eduPsychologyModulation of Nac-DA Signaling by Learning, Motivational State and PeptidesNIDAR01 DA025634June 30, 2025
Rong, Lijunlijun@uic.eduMicrobiology & ImmunologyOptimizing Ridaifen-B analogs as potential therapeutics for Ebola virusesNIAIDR01 AI168362July 31, 2027
Ross, Susansrross@uic.eduMicrobiology & ImmunologyThe role of TRIM2 and SIRPA in New World Arenavirus entryNIAIDR01 AI159290April 30, 2027
Roth, Stevenrothgas@uic.eduAnesthesiologyVRC: Engineered extracellular vesicles for mild TBI-induced retinal injuryNEIR01 EY034716May 31, 2025
Roth, Stevenrothgas@uic.eduAnesthesiologyMesenchymal stem cell extracellular vesicles for ischemic retinal damageNEIR01 EY033902May 31, 2026
Salles, Angelessalles@uic.eduBiological SciencesNeural processing of communication sounds: acoustic features and semantic contentNIDCDR00 DC019145July 31, 2025
Santosh, Sarafssaraf@uic.eduMedicine-Hematology & OncologyPathways of Cell-Free Hemoglobin in Sickle Cell NephropathyNHLBIR01 HL153161June 30, 2025
Shahrara, Shivashahrara@uic.eduMedicine-RheumatologyIdentifying a novel pathway that regulates RA immunometabolismNIAIDR01 AI167155June 30, 2027
Shukla, Deepakdshukla@uic.eduOpthlamology & Visual ScienceHSV-1 Encoded MicroRNAs in the Pathogenesis and Treatment of Ocular HerpesNEIR01 EY033622December 31, 2025
Shukla, Deepakdshukla@uic.eduOpthlamology & Visual ScienceCore Grant for Vision ResearchNEIP30 EY001792August 31, 2026
Shukla, Deepakdshukla@uic.eduOpthlamology & Visual ScienceAlleviation of ER stress as a translational strategy to curb ocular viral infectionsNEIR24 EY033598December 31, 2026
Song, Zhenyuansong2008@uic.eduKinesiology & NutritionHepatic Nicotinamide N-Methyltransferase (NNMT) as a Pathogenetic Mechanism and Therapeutic Target for Alcoholic Liver DiseaseNIAAAR01 AA030255May 31, 2027
Stocco, Carloscostocco@uic.eduPhysiology & BiophysicsSalt-Inducible Kinase Regulation of Ovarian Granulosa CellsNICHDR01 HD097202May 31, 2024
Tiruppathi, Chinnaswamytiruc@uic.eduPharmacology & Regenerative MedicineTranscription Factor Elf2 Signals Resolution of Lung InjuryNHLBIR01 HL156965February 28, 2025
Wang, Jimzjwang@uic.eduPharmaceutical SciencesMolecular mechanism and targeting of chronic pain in sickle cell diseaseNHLBIR35 HL140031December 31, 2024
Wang, Xiaoweixwang317@uic.eduPharmacology & Regenerative MedicineCombined Computational and Experimental Analyses of Gene Regulation by MicroRNAsNIGMSR35 GM141535May 31, 2026
Xu, Pingwenpingwenx@uic.eduMedicine-Endocrinology/Diabetes & MetabolismTestosterone and estrogen signaling pathways in the medial amygdala interact to control energy homeostasisNIDDKR01 DK123098June 30, 2025
Zak, Josephjdzak@uic.eduBiological SciencesLearning-mediated plasticity in cortical feedback projections to the olfactory bulbNIDCDR00 DC017754February 28, 2025

After identifying a candidate/mentor PI pair, it is imperative that the PI reach out to the PO of the parent grant and any IC-specific contacts associated with the appropriate administrative supplement program in that IC to confirm eligibility of the parent grant and candidate, confirm funding priorities of the IC, and confirm IC-specific submission components and deadlines. The candidate and PI will then work together to prepare and submit the supplement application.

This image graphically depicts the process of applying for a diversity or re-entry/reintegration supplement. 1. Identify candidate/mentor. 2. Confirm eligibility. NOTE: Each NIH IC has its own funding priorities and eligibility requirements for both the candidate and the PI/parent grant. Reach out to parent grant PO and IC-specific supplement program contacts before proceeding. 3. Prepare supplement application. NOTE: Each NIH IC has its own requirements for research plan components and other required documents. 4. Submit supplement application. NOTE: Each NIH IC has its own submission cycles and timelines for application review and funding decisions. 5. Funding decision. NOTE: The duration of postdoc support available is dependent on the NIH IC. The timeline for the entire process is IC-dependent, but it is recommended that you allow at least 6 months.

 

Before getting started, review the specific requirements for your IC and reach out to the program officer (PO) for the parent grant as well as any institute-specific contacts listed in the specific supplement application instructions for that particular IC. Additional information on submitting administrative supplements can be found here.

It is critical that applicants follow the instructions for their submission option (SF424 (R&R) Application Guide) except where instructed in funding opportunity announcement:

  • Administrative Supplements to Existing NIH Grants and Cooperative Agreements (PA-20-272)
    • Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry, Re-integration, and Re-Training into Health-Related Research Careers (NOT-OD-23-170)
    • List of eligible Activity Codes (PA-18-592)

The flowchart below depicts the components typically included in a supplement submission.

The main component of the supplement submission is the research plan, which is 6 pages or less. Click here for an example of a funded postdoc diversity supplement research plan from the University of Washington.

Pay close attention to IC-specific instructions for preparing the supplement application, as each IC has its own requirements. Components that may have IC-specific instructions are indicated by the yellow triangles.

 

This image depicts a flowchart of the supplement application components. NOTE: Before beginning, the candidate will need an eRA Commons account. Supplement application components include: 1. R&R Cover form; 2. Research Plan form (<6 pages), NOTE: Each IC has its own instructions and specific sections to be included in the Research Plan, which may include a. summary of the funded parent grant, b. detailed research plan and relevance to parent grant, c. career development plan, d. mentorship plan and e. research and career development timeline proposed for the candidate; 3. Project/Performance Site Locations form; 4. Senior/Key Personnel Profile (Expanded) form including biographical Sketches for PI, candidate, and all senior/key personnel; 5. R&R Other Project Information form including a. Assurances for Human Subjects Research and Vertebrate Animals, b. Home Institution Approval and Sub-recipient Approval, c. PHS Human Subjects and Clinical Trials Information Form, and d. candidate eligibility statement, which includes basis for candidate’s eligibility in the program, candidate citizenship, and how the appointment of the specific candidate furthers the goals of the funding opportunity. NOTE: Some ICs may request a description of any current or previous Public Health Service research grant support that the candidate has received; 6. Budget form. NOTE: Review IC-specific budget requirements. Additional requirements of some ICs may include candidate personal statement, candidate statement of career goals, statement of PI mentor qualifications, detailed mentoring plan, Responsible Conduct of Research, and letters of recommendation.